Francesco Leonardi

机构：Associazione Italiana Di Oncologia Medica · ORCID：0000-0002-3001-8960

发表论文 116 篇 · 总被引 2030 次 · h-index 22

代表论文

• Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial (2023 · The Lancet · 被引 530)
• A Simple Overview of Pancreatic Cancer Treatment for Clinical Oncologists (2023 · Current Oncology · 被引 45)
• Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study (2023 · Leukemia · 被引 26)
• INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a multicenter prospective observational study (INVIDIa-2) (2021 · Journal for ImmunoTherapy of Cancer · 被引 24)
• Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial (2021 · European Journal of Cancer · 被引 15)
• Three distinct outcomes in patients with colorectal adenocarcinoma and lymphovascular invasion: the good, the bad, and the ugly (2021 · International Journal of Colorectal Disease · 被引 14)